ACD/Labs has released version 2024 of the Spectrus Platform, which offers contract laboratories significant enhancements to their data management and analysis workflows. With improved AI capabilities and better integration with third-party systems, the new Spectrus release supports contract labs in delivering faster and more reliable results.
The Spectrus Platform 2024 is particularly beneficial for labs involved in pharmaceutical process development, where accelerated stability study support helps determine drug expiry and shelf life. The introduction of browser-based tools like Spectrus Processor JS also adds flexibility for labs managing a diverse range of data from multiple instruments.
How contract laboratories benefit from this new data management system:
- Improved Data Management: Centralized system for seamless data collection and sharing.
- Enhanced AI Tools: Automates data analysis, providing faster, actionable insights for clients.
- Third-Party Integration: Ensures compatibility with existing software, minimizing disruptions.
- Accelerated Stability Studies: Supports faster drug development cycles with reliable data.
- Advanced NMR and MS Analysis: Boosts accuracy in compound identification and quantification.
For contract laboratories, the Spectrus Platform 2024 offers a robust solution to meet the growing demands for faster, more efficient data processing and reporting.
This article is a summary of a published press release provided by ACD/Labs
